Tibra Equities Europe’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-11,800
Closed -$3.56M 42
2019
Q4
$3.56M Buy
+11,800
New +$3.25M 0.5% 31

Other funds holding ELV

Tibra Equities Europe's ELV Position: Q1 2020 in Review

Tibra Equities Europe sold out of Elevance Health (ELV) in Q1 2020, closing a stake of 11,800 shares — an estimated $3.56M sold.

Tibra Equities Europe first reported a position in ELV in Q4 2019 and held it in 1 quarter. The position peaked at $3.56M in Q4 2019. 1,051 funds tracked by Wall St. Rank hold ELV as of Q1 2020.

  • Tibra Equities Europe reported no remaining Elevance Health position as of Q1 2020 after selling out during the quarter.
  • Tibra Equities Europe sold 11,800 Elevance Health shares in Q1 2020, an estimated $3.56M.
  • Tibra Equities Europe first reported a position in Elevance Health in Q4 2019 and held it in 1 quarter.
  • Tibra Equities Europe's Elevance Health position peaked at $3.56M in Q4 2019.
  • 1,051 funds tracked by Wall St. Rank held Elevance Health as of Q1 2020.

Based on Tibra Equities Europe's 13F filing for Q1 2020, filed 15 May 2020.